Paragon Fine And Speciality Chemical Limited · NSE:PARAGON
Paragon Fine And Speciality Chemical — Investor Presentation (August 2024)
16 slides from Paragon Fine And Speciality Chemical's investor presentation, Aug 19, 2024
Slide 1: Intimation of Knowledge Session and Investor Presentation
Date: 19.08.2024 To, Listing Department National Stock Exchange of India Limited Exchange Plaza, 5th Floor, Plot No. C/1, G Block, Bandra-Kurla Complex, Bandra (E) Mumbai – 400051 Symbol: PARAGON SUB: INTIMATION OF KNOWLEDGE SESSION AND INVESTOR PRESENTATION Dear Sir / Madam, In accordance with the
Slide 2: H2 & FY24 Investor Presentation
PARAGON FINE & SPECIALITY CHEMICAL LTD H2 & FY24 Investor Presentation August 2024
Slide 3: Disclaimer
Disclaimer This presentation and the accompanying slides (the “Presentation”), which have been prepared by Paragon Fine & Speciality Chemical Ltd (the “Company”), have been prepared solely for information purposes and do not constitute any offer, recommendation or invitation to purchase or subscribe
Slide 4: PFSCL - Our Business
PFSCL- Our Business Revenue • Leading global supplier of specialty intermediates EBITDA CAGR CAGR 14% (FY21-24) 47% (FY21-24) • Industries Served : o Specialty Pigments & Dye PAT o Agrochemical CAGR ROCE o Cosmetic 48% (FY21-24) 40% (FY24) o Pharmaceuticals o Electronics CFO ROE Rs 0.20 Cr 57% (FY24
Slide 5: Our Journey
Our Journey 2004 2022 2024 • Commenced Operations for chemical • 8000 certification attained alongside One • Client based Increased to 94 manufacturing and sales Star Export House accreditation • Revenue touched Rs 122 Cr. • Started producing of dye intermediates and a range of broadening product. G
Slide 6: Paragon's Growth and Product Strategy
Paragon’s Growth and Product Strategy Growing Revenue Expanding Margin CAGR: 14% 16.3% 14.0% 7.5% 7.1% 19.8 122.0 104.1 14.6 83.3 82.8 6.2 5.9 FY21 FY22 FY23 FY24 FY21 FY22 FY23 FY24 EBITDA (Rs Cr) EBITDA Margin % o Company's growth is on an upward trajectory, with current capacity at 650 MTPA and p
Slide 7: Improving Profitability
Improving Profitability Expanding margins: Increasing returns , Creating shareholder value Expanding Margin Enabling Shareholders’ Return 16.3% 55.3% 57.0% 14.0% 15.6% 39.7% 13.2% 36.1% 11.8% 27.0% 7.5% 7.1% 9.5% 28.2% 6.2% 6.7% 19.5% 21.9% 5.3% 5.4% FY21 FY22 FY23 FY24 FY21 FY22 FY23 FY24 EBITDA Ma
Slide 8: Our USP
Our USP Formidable Foundations - Our Unbeatable USPs o Solid Foundations: Partnering with Global Industry Global Leaders: Our Clientele Leaders Trusted by established o Proven Excellence: Delivering Quality to Top-tier MNCs Enterprises o Everlight Chemical Industrial Corporation o Developed over 50
Slide 9: Specialised in Complex Chemistries
Specialised in Complex Chemistries o High barriers exist due to o Our team has complex catalytic processes o PFSCL, one of India's successfully conducted and the demand for advanced largest suppliers of multi-step synthesis and technical and R&D capabilities Chloranil and Dichlone scale-up for numer
Slide 10: Emerging as a Key Player in a High-Barrier Industry
Emerging as a Key Player in a High-Barrier Industry Complex Catalytic Processes Technical Expertise Requirement o Processes involve intricate o Demands a high level steps and chemical reactions of specialized o PFSCL: Implementing knowledge and skills Advanced Technology Across Five Chemistry Stages
Slide 11: De-risked Business Model and Diversified Product offering
De-risked Business Model and Diversified Product offering Diversified Revenue Stream: Segmental Revenue Contribution (%) Total Revenue from Operations (Rs.Cr) 82.2 82.8 104.1 121.3 8.1% 0.6% 0.33% 12.0% 14.3% 22.1% 0.00% 1.06% 1.40% 62.6% 79.9% 68.9% 49.7% 7.12% 7.87% 6.16% 7.00% 4.4% 17.9% 9.0% 18.
Slide 12: Revenue from Top 10 Customers
Revenue from Top 10 Customers Tailored Solution, Customer Centric Success Contribution from Top 10 Customers Growing Revenue (Rs.Cr) 73.3% 78.2% 26% 17% 42.2% 41.0% -1% 60.2 64.7 43.2 121.3 49.7 104.1 83.3 82.8 FY21 FY22 FY23 FY24 FY21 FY22 FY23 FY24 Revenue(Rs Cr.) % of Contirbution Revenue(Rs Cr.)
Slide 13: Revenue from Top 10 Chemistries
Revenue from Top 10 Chemistries Top 10 Product % Contribution to Revenue 57.3% 39.7% 28.2% 34.1% 47.49 41.30 32.60 28.80 FY21 FY22 FY23 FY24 Revenue (Rs Cr.) Top 10 Product % Contribution to Revenue Product Name End user Industry 2,3 Dichloro-1,4-Naphthoquinone (Dichlone) Agro Intermediates Chlorani
Slide 14: Strong Product Pipeline
Strong Product Pipeline Product Name Description Progress Technology Remarks HALQUINOL- Feed Grade Feed additive Under Execution Chlorination Sampling Completed o GMP Registration Expected Launch timeline: awaited HALQUINOL- Pharma Antibiotic Chlorination o 40-50% enhancement Q1FY25 in Price viz a v
Slide 15: H2FY24 Financial Highlights
Financial Highlights Revenue (Rs Cr.) EBITDA (Rs Cr.) & EBITDA Margin % PAT (Rs Cr.) & PAT Margin % 14% 16.3% 9.5% 11.8% FY23 121 19.8 14.3 14.6 9.9 104 FY23 FY24 FY23 FY24 FY23 FY24 14.6% 17.9% 9.7% 13.6% H2FY24 72 8 10 11 7 61 H2FY23 H2FY24 H2FY23 H2FY24 H2FY23 H2FY24 14
Slide 16: Balance Sheet
Balance Sheet Particulars (Rs Cr.) FY24 FY23 Particulars (Rs Cr.) FY24 FY23 Assets Equity and Liabilities Non‐Current Assets Shareholders funds Plant Property and Equipment 10.9 9.4 Share Capital 19.6 3.6 Reserves and Surplus 63.9 18.7 CWIP 0.6 Net Worth 83.5 22.3 Other Intangible Assets 0.0 0.0 Non
Paragon Fine & Speciality Chemical — Investor Presentation (August 2024) on 6ix